Biostax Corp (BTAX)

[tjguy]

And I speculate that Noreen is WAY WAY underestimating the potential revenues for the coming years.

I hope so. It's much better to underestimate than overestimate and fall short.

Still, the company will have to prove that it can sell the drug. We will need to actually see some revenues and contracts to get this moving.

With 6 million in revenues projected this year, I wonder what that would translate into earnings. That's going to be the key figure.

[Oh, I see she did include a slide on net income. This year shows what - maybe a million dollars? Not sure. Maybe 15 million for next year. What will that do for the share price I wonder?]

$4.7 million in debt is still on the books. Hopefully we can retire a good portion of that debt asap!